Trial Profile
Clinical trial of SB 010 in patients with eosinophilic chronic obstructive pulmonary disease.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 10 Sep 2014
Price :
$35
*
At a glance
- Drugs Anti-GATA3 gene-therapy (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Adverse reactions; Therapeutic Use
- 10 Sep 2014 New trial record